# Writing Guidance - æ™ºèƒ½å†™ä½œå¯¼å¸ˆçŸ¥è¯†åº“
# ACS-Mentor V2.0 Core Module
# ç ”ç©¶å…¨å‘¨æœŸå†™ä½œæ”¯æŒï¼šä»æ„æ€åˆ°å‘è¡¨

# ============================================================================
# Writing Phases - å†™ä½œé˜¶æ®µæ”¯æŒ
# ============================================================================

writing_phases:

  # --------------------------------------------------------------------------
  # Phase 1: Ideation (æ„æ€é˜¶æ®µ)
  # --------------------------------------------------------------------------

  ideation:
    description: "ä»æ¨¡ç³Šæƒ³æ³•åˆ°æ¸…æ™°ç ”ç©¶é—®é¢˜"

    guidance_areas:
      - research_question_refinement      # ç ”ç©¶é—®é¢˜ç²¾ç‚¼
      - literature_gap_identification     # æ–‡çŒ®gapè¯†åˆ«
      - theoretical_framework_selection   # ç†è®ºæ¡†æ¶é€‰æ‹©
      - hypothesis_formulation            # å‡è®¾å½¢æˆ

    intervention_patterns:

      when_question_vague:
        trigger_keywords: ["æƒ³ç ”ç©¶", "æ„Ÿå…´è¶£", "ä¸ç¡®å®šç ”ç©¶ä»€ä¹ˆ", "ç ”ç©¶æ–¹å‘"]
        template: |
          ğŸ’¡ ç ”ç©¶é—®é¢˜ç²¾ç‚¼æ¡†æ¶

          æ‚¨çš„ç ”ç©¶å…´è¶£æ˜¯ {topic}ï¼Œè®©æˆ‘ä»¬ä¸€èµ·æ˜ç¡®ç ”ç©¶é—®é¢˜ï¼š

          1ï¸âƒ£ **æ ¸å¿ƒé—®é¢˜** (What)
          - å…·ä½“è¦ç ”ç©¶ä»€ä¹ˆç°è±¡/å…³ç³»/æ•ˆæœï¼Ÿ
          - èƒ½ç”¨ä¸€å¥è¯é™ˆè¿°å—ï¼Ÿ

          2ï¸âƒ£ **é‡è¦æ€§** (Why)
          - ä¸ºä»€ä¹ˆè¿™ä¸ªé—®é¢˜å€¼å¾—ç ”ç©¶ï¼Ÿ
          - å¯¹å­¦æœ¯/ä¸´åºŠ/æ”¿ç­–æœ‰ä»€ä¹ˆæ„ä¹‰ï¼Ÿ

          3ï¸âƒ£ **ç ”ç©¶ç°çŠ¶** (Gap)
          - ç°æœ‰ç ”ç©¶åšäº†ä»€ä¹ˆï¼Ÿ
          - è¿˜æœ‰ä»€ä¹ˆæ²¡åšæˆ–åšå¾—ä¸å¤Ÿå¥½ï¼Ÿ

          4ï¸âƒ£ **ç‹¬ç‰¹è´¡çŒ®** (Novelty)
          - æ‚¨çš„ç ”ç©¶æœ‰ä»€ä¹ˆç‹¬ç‰¹ä¹‹å¤„ï¼Ÿ
          - ä¸ç°æœ‰ç ”ç©¶çš„å·®å¼‚åœ¨å“ªé‡Œï¼Ÿ

          åŸºäºè¿™ä¸ªæ¡†æ¶ï¼Œæ‚¨å¯ä»¥å°è¯•å¡«å†™ï¼Œæˆ‘ä¼šå¸®æ‚¨è¿›ä¸€æ­¥å®Œå–„ã€‚

      when_gap_unclear:
        trigger_keywords: ["ä¸çŸ¥é“gap", "æ–‡çŒ®ç»¼è¿°ä¸çŸ¥é“å†™ä»€ä¹ˆ", "åˆ›æ–°ç‚¹"]
        template: |
          ğŸ” æ–‡çŒ®gapè¯†åˆ«ç­–ç•¥

          é’ˆå¯¹ {topic} é¢†åŸŸï¼Œæˆ‘å»ºè®®ä¸‰ä¸ªè¯†åˆ«gapçš„æ–¹æ³•ï¼š

          **æ–¹æ³•1: ç³»ç»Ÿç»¼è¿°æ³•**
          - æœç´¢è¿‘5å¹´çš„systematic reviews/meta-analyses
          - é‡ç‚¹å…³æ³¨"limitations"å’Œ"future research"ç« èŠ‚
          - è¿™äº›å¾€å¾€ç›´æ¥æŒ‡å‡ºäº†gap

          **æ–¹æ³•2: çŸ›ç›¾è¯†åˆ«æ³•**
          - å¯»æ‰¾ç ”ç©¶ç»“æœçš„çŸ›ç›¾ä¹‹å¤„
          - åˆ†æä¸ºä»€ä¹ˆä¼šæœ‰çŸ›ç›¾ï¼ˆè®¾è®¡ï¼Ÿäººç¾¤ï¼Ÿæ–¹æ³•ï¼Ÿï¼‰
          - çŸ›ç›¾å¾€å¾€æ˜¯åˆ›æ–°ç‚¹

          **æ–¹æ³•3: æ–¹æ³•å­¦åˆ›æ–°æ³•**
          - è¯†åˆ«ç°æœ‰ç ”ç©¶çš„å…±åŒæ–¹æ³•å­¦å±€é™
          - è€ƒè™‘ï¼šèƒ½å¦ç”¨æ›´å¥½çš„è®¾è®¡/åˆ†ææ–¹æ³•ï¼Ÿ
          - èƒ½å¦åœ¨æ–°äººç¾¤/æ–°ç¯å¢ƒéªŒè¯ï¼Ÿ

          æ‚¨æƒ³ä»å“ªä¸ªæ–¹æ³•å…¥æ‰‹ï¼Ÿæˆ‘å¯ä»¥æä¾›å…·ä½“æŒ‡å¯¼ã€‚

      when_needs_framework:
        trigger_keywords: ["ç†è®ºæ¡†æ¶", "conceptual model", "æœºåˆ¶"]
        template: |
          ğŸ—ï¸ ç†è®ºæ¡†æ¶æ„å»ºæŒ‡å¯¼

          ç ”ç©¶ {topic} æ—¶ï¼Œç†è®ºæ¡†æ¶å¸®åŠ©æ‚¨ï¼š
          - æ˜ç¡®å…³é”®å˜é‡å’Œå®ƒä»¬çš„å…³ç³»
          - æŒ‡å¯¼ç ”ç©¶è®¾è®¡å’Œæµ‹é‡
          - è§£é‡Šç»“æœå’Œæœºåˆ¶

          **å¸¸è§æ¡†æ¶ç±»å‹**ï¼š

          1. å› æœè·¯å¾„æ¡†æ¶ (Causal pathway)
             - X â†’ Mediator â†’ Y
             - é€‚ç”¨äºï¼šæœºåˆ¶ç ”ç©¶

          2. å¤šå› ç´ æ¨¡å‹ (Multifactorial model)
             - X1, X2, X3... â†’ Y
             - é€‚ç”¨äºï¼šé¢„æµ‹ç ”ç©¶ã€é£é™©å› ç´ è¯†åˆ«

          3. è°ƒèŠ‚æ•ˆåº”æ¡†æ¶ (Moderation)
             - X â†’ Y, ä½†æ•ˆåº”å¤§å°å–å†³äºModerator
             - é€‚ç”¨äºï¼šå¼‚è´¨æ€§ç ”ç©¶ã€ä¸ªä½“åŒ–åŒ»ç–—

          åŸºäºæ‚¨çš„ç ”ç©¶é—®é¢˜ï¼Œæˆ‘å»ºè®® {recommended_framework}ã€‚

  # --------------------------------------------------------------------------
  # Phase 2: Design (è®¾è®¡é˜¶æ®µ)
  # --------------------------------------------------------------------------

  design:
    description: "ä»ç ”ç©¶é—®é¢˜åˆ°å¯æ‰§è¡Œæ–¹æ¡ˆ"

    guidance_areas:
      - study_design_selection      # ç ”ç©¶è®¾è®¡é€‰æ‹©
      - statistical_method_selection # ç»Ÿè®¡æ–¹æ³•é€‰æ‹©
      - sample_size_justification   # æ ·æœ¬é‡è®ºè¯
      - data_collection_planning    # æ•°æ®æ”¶é›†è§„åˆ’

    # ç ”ç©¶è®¾è®¡å†³ç­–æ ‘
    design_decision_tree:

      research_question_type:

        causal_inference:
          description: "ç ”ç©¶Xæ˜¯å¦å¯¼è‡´Y"
          gold_standard: "Randomized Controlled Trial (RCT)"

          alternatives:
            - name: "Instrumental Variables (IV)"
              when: "RCTä¸å¯è¡Œï¼Œä½†æœ‰valid instrument"
              requirements:
                - "Instrumentä¸Xå¼ºç›¸å…³"
                - "Instrumentä»…é€šè¿‡Xå½±å“Y"
                - "Instrumentä¸æ··æ‚å› ç´ æ— å…³"

            - name: "Regression Discontinuity Design (RDD)"
              when: "æœ‰æ˜ç¡®çš„cutoffå†³å®štreatment"
              requirements:
                - "Cutoffé™„è¿‘as-if random"
                - "è¶³å¤Ÿçš„æ ·æœ¬åœ¨cutoffé™„è¿‘"

            - name: "Difference-in-Differences (DID)"
              when: "æœ‰treatmentå’Œcontrolç»„çš„å‰åæ•°æ®"
              requirements:
                - "Parallel trends assumption"
                - "No spillover effects"

          guidance_template: |
            æ‚¨æƒ³ç ”ç©¶ {exposure} æ˜¯å¦å¯¼è‡´ {outcome}ã€‚

            **ç†æƒ³è®¾è®¡**: RCT
            - éšæœºåˆ†é…exposure
            - æ§åˆ¶å·²çŸ¥å’ŒæœªçŸ¥æ··æ‚

            **RCTä¸å¯è¡Œæ—¶**ï¼Œè€ƒè™‘å‡†å®éªŒè®¾è®¡ï¼š

            {list_alternatives_with_requirements}

            **å¦‚æœåªèƒ½åšè§‚å¯Ÿæ€§ç ”ç©¶**ï¼š
            1. ç»˜åˆ¶DAG (Directed Acyclic Graph)
            2. è¯†åˆ«æœ€å°å……åˆ†è°ƒæ•´é›†
            3. è¿›è¡Œæ•æ„Ÿæ€§åˆ†æ
            4. è¯­è¨€è°¨æ…ï¼šç”¨"association"è€Œé"causation"

        prediction:
          description: "æ„å»ºé¢„æµ‹æ¨¡å‹"

          key_decisions:
            - decision: "é¢„æµ‹ç›®æ ‡ç±»å‹"
              options:
                - "è¯Šæ–­ (Diagnostic prediction)"
                - "é¢„å (Prognostic prediction)"
                - "æ²»ç–—ååº” (Treatment response)"

            - decision: "é¢„æµ‹æ—¶é—´çª—å£"
              considerations:
                - "æ—¶é—´ç‚¹é¢„æµ‹ vs. æ—¶é—´çª—é¢„æµ‹"
                - "çŸ­æœŸ vs. é•¿æœŸé¢„å"

            - decision: "éªŒè¯ç­–ç•¥"
              requirements:
                - "å†…éƒ¨éªŒè¯ï¼ˆå¿…éœ€ï¼‰ï¼šBootstrapæˆ–CV"
                - "æ—¶é—´éªŒè¯ï¼ˆæ¨èï¼‰ï¼šTemporal validation"
                - "å¤–éƒ¨éªŒè¯ï¼ˆé‡‘æ ‡å‡†ï¼‰ï¼šç‹¬ç«‹é˜Ÿåˆ—"

          guidance_template: |
            é¢„æµ‹æ¨¡å‹ç ”ç©¶çš„å…³é”®è®¾è®¡è¦ç´ ï¼š

            1ï¸âƒ£ **æ˜ç¡®é¢„æµ‹ç›®æ ‡**
            - è¯Šæ–­ vs. é¢„å vs. æ²»ç–—ååº”ï¼Ÿ
            - é¢„æµ‹æ—¶é—´çª—å£ï¼Ÿï¼ˆå¦‚ï¼š6ä¸ªæœˆå†…çš„å¤å‘ï¼‰

            2ï¸âƒ£ **æ ·æœ¬é‡è§„åˆ’**
            - è§„åˆ™ï¼šæ¯ä¸ªé¢„æµ‹å˜é‡è‡³å°‘10-20ä¸ªevents
            - ä¾‹ï¼š10ä¸ªå˜é‡çš„logisticæ¨¡å‹éœ€è¦100-200ä¸ªevents

            3ï¸âƒ£ **éªŒè¯ç­–ç•¥**ï¼ˆè¿™æ˜¯å¼ºåˆ¶è¦æ±‚ï¼ï¼‰
            - æœ€ä½è¦æ±‚ï¼šå†…éƒ¨éªŒè¯ï¼ˆBootstrap 200+æ¬¡æˆ–10-fold CVï¼‰
            - å¼ºçƒˆæ¨èï¼šå¤–éƒ¨éªŒè¯ï¼ˆä¸åŒåŒ»é™¢/åœ°åŒº/æ—¶é—´ï¼‰

            4ï¸âƒ£ **ä¸´åºŠå®ç”¨æ€§è¯„ä¼°**
            - Decision curve analysis
            - Net benefitè®¡ç®—
            - ä¸ç°æœ‰æ–¹æ³•æ¯”è¾ƒ

        descriptive:
          description: "æè¿°æ€§/æ¢ç´¢æ€§ç ”ç©¶"

          focus_areas:
            - "Representativeness (ä»£è¡¨æ€§)"
            - "Generalizability (å¯æ¨å¹¿æ€§)"
            - "Subgroup heterogeneity (å¼‚è´¨æ€§)"

          guidance_template: |
            æè¿°æ€§ç ”ç©¶çš„ä»·å€¼æœ€å¤§åŒ–ç­–ç•¥ï¼š

            1ï¸âƒ£ **æ˜ç¡®æ ·æœ¬ä»£è¡¨æ€§**
            - æ‚¨çš„æ ·æœ¬ä»£è¡¨å“ªä¸ªäººç¾¤ï¼Ÿ
            - çº³å…¥/æ’é™¤æ ‡å‡†çš„ç†ç”±ï¼Ÿ
            - ä¸ä¸€èˆ¬äººç¾¤çš„å·®å¼‚ï¼Ÿ

            2ï¸âƒ£ **ä¸å·²æœ‰ç ”ç©¶å¯¹æ¯”**
            - æ‚¨çš„å‘ç°ä¸æ–‡çŒ®ä¸€è‡´å—ï¼Ÿ
            - å¦‚ä¸ä¸€è‡´ï¼Œå¯èƒ½åŸå› æ˜¯ï¼Ÿ
            - è¿™æä¾›äº†ä»€ä¹ˆæ–°ä¿¡æ¯ï¼Ÿ

            3ï¸âƒ£ **æ¢ç´¢å¼‚è´¨æ€§**
            - ä¸åŒäºšç»„çš„æ¨¡å¼æœ‰å·®å¼‚å—ï¼Ÿ
            - è¿™äº›å·®å¼‚æœ‰ä¸´åºŠæ„ä¹‰å—ï¼Ÿ
            - ä¸ºæœªæ¥ç ”ç©¶ç”Ÿæˆå‡è®¾

            4ï¸âƒ£ **è¯šå®æŠ¥å‘Šå±€é™**
            - å•ä¸­å¿ƒ vs. å¤šä¸­å¿ƒ
            - é€‰æ‹©åå€šçš„å¯èƒ½æ€§
            - Generalizabilityçš„é™åˆ¶

    # ç»Ÿè®¡æ–¹æ³•é¡¾é—®
    statistical_method_advisor:

      by_outcome_type:

        continuous:
          normal_distribution:
            - method: "Linear Regression"
              when: "éœ€è¦è°ƒæ•´åå˜é‡"
              assumptions: ["çº¿æ€§å…³ç³»", "æ®‹å·®æ­£æ€", "æ–¹å·®é½æ€§", "ç‹¬ç«‹æ€§"]
              check: "Residual plots"

            - method: "t-test / ANOVA"
              when: "ç®€å•ç»„é—´æ¯”è¾ƒ"
              assumptions: ["æ­£æ€åˆ†å¸ƒ", "æ–¹å·®é½æ€§"]
              check: "Shapiro-Wilk test, Levene's test"

          non_normal:
            - method: "Quantile Regression"
              when: "å¯¹å¼‚å¸¸å€¼ç¨³å¥"
              advantage: "ä¸éœ€è¦æ­£æ€å‡è®¾"

            - method: "Log-transformation + Linear Regression"
              when: "å³åæ•°æ®"
              note: "ç»“æœè§£é‡Šä¸ºå‡ ä½•å¹³å‡æ•°"

            - method: "Non-parametric tests (Mann-Whitney, Kruskal-Wallis)"
              when: "åˆ†å¸ƒä¸¥é‡åç¦»æ­£æ€"
              limitation: "æ£€éªŒæ•ˆèƒ½è¾ƒä½"

        binary:
          - method: "Logistic Regression"
            when: "æœ€å¸¸ç”¨é€‰æ‹©ï¼Œä¼°è®¡OR"
            output: "Odds Ratio (OR)"
            note: "ç½•è§äº‹ä»¶æ—¶ORâ‰ˆRR"

          - method: "Log-binomial Regression"
            when: "æ‚£ç—…ç‡>10%ï¼Œæƒ³ä¼°è®¡RR"
            output: "Risk Ratio (RR)"
            note: "RRæ¯”ORæ›´æ˜“è§£é‡Š"

          - method: "Poisson Regression with robust SE"
            when: "Log-binomialä¸æ”¶æ•›æ—¶çš„æ›¿ä»£"
            output: "Risk Ratio (RR)"

        time_to_event:
          - method: "Cox Proportional Hazards Model"
            when: "ç”Ÿå­˜åˆ†æçš„é»˜è®¤é€‰æ‹©"
            assumption: "Proportional hazards (PH)"
            check: "Schoenfeld residuals test"
            output: "Hazard Ratio (HR)"

          - method: "Parametric Survival Models (Weibull, etc.)"
            when: "PHå‡è®¾è¿åæˆ–éœ€è¦å¤–æ¨"
            advantage: "å¯é¢„æµ‹median survival time"

          - method: "Time-dependent Cox model"
            when: "åå˜é‡éšæ—¶é—´å˜åŒ–"
            example: "Treatment switching"

        count:
          - method: "Poisson Regression"
            when: "Count outcomeï¼Œå‡å€¼â‰ˆæ–¹å·®"
            check: "Dispersion parameter â‰ˆ 1"

          - method: "Negative Binomial Regression"
            when: "Over-dispersion (æ–¹å·®>å‡å€¼)"
            note: "æ›´å¸¸ç”¨äºå®é™…æ•°æ®"

      advanced_topics:
        missing_data:
          approaches:
            - name: "Complete Case Analysis"
              when: "MCARä¸”ç¼ºå¤±<5%"
              risk: "Bias if not MCAR, power loss"

            - name: "Multiple Imputation"
              when: "MARï¼Œç¼ºå¤±5-40%"
              recommendation: "M=20-50 imputations"
              software: "mice (R), mi (Python)"

            - name: "Sensitivity Analysis"
              when: "Concerned about MNAR"
              approach: "Pattern mixture models"

        mediation_analysis:
          framework: "Causal mediation (VanderWeele)"
          requirements:
            - "No unmeasured confounding of Xâ†’M, Mâ†’Y, Xâ†’Y"
            - "No X-M interaction affecting Y"
          output:
            - "Natural Direct Effect (NDE)"
            - "Natural Indirect Effect (NIE)"
            - "Proportion mediated"

  # --------------------------------------------------------------------------
  # Phase 3: Analysis (åˆ†æé˜¶æ®µ)
  # --------------------------------------------------------------------------

  analysis:
    description: "ä»æ•°æ®åˆ°æ´å¯Ÿ"

    guidance_areas:
      - analysis_strategy        # åˆ†æç­–ç•¥
      - result_interpretation    # ç»“æœè§£è¯»
      - visualization_design     # å¯è§†åŒ–è®¾è®¡
      - sensitivity_analysis     # æ•æ„Ÿæ€§åˆ†æ

    # å¯è§†åŒ–åŸåˆ™
    visualization_principles:

      figure_types:

        comparison:
          recommended:
            - name: "Forest Plot"
              use: "å±•ç¤ºå¤šä¸ªæ•ˆåº”é‡åŠCI"
              example: "Meta-analysis, äºšç»„åˆ†æ"

            - name: "Coefficient Plot"
              use: "å›å½’ç³»æ•°å¯è§†åŒ–"
              advantage: "æ¯”è¡¨æ ¼æ›´ç›´è§‚"

            - name: "Violin Plot"
              use: "å±•ç¤ºåˆ†å¸ƒ+æ¯”è¾ƒ"
              advantage: "æ¯”box plotä¿¡æ¯æ›´ä¸°å¯Œ"

          avoid:
            - "3D charts (éš¾ä»¥è§£è¯»)"
            - "Pie charts for >5 categories (è§’åº¦éš¾æ¯”è¾ƒ)"

        distribution:
          recommended:
            - name: "Histogram + Density Curve"
              use: "å±•ç¤ºè¿ç»­å˜é‡åˆ†å¸ƒ"

            - name: "Box Plot + Jitter Points"
              use: "å±•ç¤ºåˆ†å¸ƒ+outliers"

          avoid:
            - "Bar charts for continuous data (ä¿¡æ¯ä¸¢å¤±)"

        association:
          recommended:
            - name: "Scatter Plot + Smooth"
              use: "åŒè¿ç»­å˜é‡å…³ç³»"
              enhancement: "Add confidence band"

            - name: "Heatmap"
              use: "ç›¸å…³æ€§çŸ©é˜µå¯è§†åŒ–"
              tip: "Cluster rows/columns"

      design_checklist:
        essential_elements:
          - "åæ ‡è½´æ¸…æ™°æ ‡æ³¨ï¼ˆå«å•ä½ï¼‰"
          - "Error barså®šä¹‰ï¼ˆSE vs. CI vs. SDï¼‰"
          - "æ ·æœ¬é‡æ ‡æ³¨"
          - "ç»Ÿè®¡æ˜¾è‘—æ€§æ ‡è®°ï¼ˆå¦‚é€‚ç”¨ï¼‰"

        quality_enhancements:
          - "Color-blind friendly palette (æ¨èviridis)"
          - "è¶³å¤Ÿçš„å­—ä½“å¤§å°ï¼ˆ>10ptï¼‰"
          - "é«˜åˆ†è¾¨ç‡ï¼ˆâ‰¥300 dpi for publicationï¼‰"
          - "Self-contained caption"

    # ç»“æœè§£è¯»æŒ‡å¯¼
    interpretation_guidance:

      statistical_vs_clinical:
        template: |
          âš ï¸ ç»Ÿè®¡æ˜¾è‘—æ€§ â‰  ä¸´åºŠé‡è¦æ€§

          æ‚¨çš„ç»“æœï¼š{statistic} = {value}, p = {p_value}

          **ç»Ÿè®¡å±‚é¢**ï¼š
          - p < 0.05ï¼Œreject null hypothesis

          **ä¸´åºŠå±‚é¢**éœ€è¦è€ƒè™‘ï¼š
          1ï¸âƒ£ **æ•ˆåº”é‡å¤§å°**
          - æ•ˆåº”é‡æ˜¯ {effect_size}
          - ä¸´åºŠä¸Šè¿™ä¸ªå¤§å°æœ‰æ„ä¹‰å—ï¼Ÿ

          2ï¸âƒ£ **ç½®ä¿¡åŒºé—´**
          - 95% CI: [{ci_lower}, {ci_upper}]
          - CIåŒ…å«ä¸´åºŠé‡è¦é˜ˆå€¼å—ï¼Ÿ

          3ï¸âƒ£ **NNT/NNH**ï¼ˆå¦‚é€‚ç”¨ï¼‰
          - éœ€è¦æ²»ç–—å¤šå°‘äººè·å¾—1ä¸ªé¢å¤–è·ç›Šï¼Ÿ

          å»ºè®®åœ¨Discussionä¸­æ˜ç¡®åŒºåˆ†ç»Ÿè®¡ä¸ä¸´åºŠæ„ä¹‰ã€‚

      null_results:
        template: |
          é˜´æ€§ç»“æœçš„è§£è¯»æ¡†æ¶

          æ‚¨çš„ç»“æœï¼šp = {p_value} (non-significant)

          **å¯èƒ½çš„è§£é‡Š**ï¼š

          1ï¸âƒ£ **çœŸçš„æ²¡æœ‰æ•ˆåº”** (True null)
          - è¿™æ˜¯æœ‰ä»·å€¼çš„å‘ç°ï¼
          - å¯ä»¥ç»ˆæ­¢æ— æ•ˆå¹²é¢„çš„ç ”ç©¶

          2ï¸âƒ£ **ç»Ÿè®¡åŠŸæ•ˆä¸è¶³** (Underpowered)
          - æ‚¨çš„æ ·æœ¬é‡æ˜¯ N = {n}
          - Post-hoc power: {power}
          - å¯èƒ½å­˜åœ¨æ•ˆåº”ä½†æœªæ£€æµ‹åˆ°

          3ï¸âƒ£ **æ•ˆåº”é‡å¤ªå°** (Small effect)
          - CI: [{ci_lower}, {ci_upper}]
          - å¯èƒ½æœ‰å¾®å°æ•ˆåº”ï¼Œä½†ä¸´åºŠä¸é‡è¦

          4ï¸âƒ£ **å¼‚è´¨æ€§** (Heterogeneity)
          - æ€»ä½“æ— æ•ˆåº”ï¼Œä½†æŸäº›äºšç»„æœ‰æ•ˆåº”
          - è€ƒè™‘æ¢ç´¢æ€§äºšç»„åˆ†æ

          å»ºè®®ï¼šè¯šå®æŠ¥å‘Šï¼Œå¼ºè°ƒç ”ç©¶çš„è´¡çŒ®ã€‚

  # --------------------------------------------------------------------------
  # Phase 4: Writing (å†™ä½œé˜¶æ®µ)
  # --------------------------------------------------------------------------

  writing:
    description: "ä»ç»“æœåˆ°å‘è¡¨"

    guidance_areas:
      - structure_optimization      # ç»“æ„ä¼˜åŒ–
      - argument_strengthening      # è®ºè¯åŠ å¼º
      - discussion_deepening        # è®¨è®ºæ·±åŒ–
      - limitation_honesty          # å±€é™æ€§è¯šå®

    # Discussionç»“æ„æ¡†æ¶
    discussion_framework:

      sections:
        - section: "Principal Findings"
          length: "1 paragraph"
          content_guide: |
            **ç›®çš„**ï¼šç®€æ˜æ€»ç»“ä¸»è¦å‘ç°

            **åŒ…å«**ï¼š
            - æœ€é‡è¦çš„1-3ä¸ªå‘ç°
            - å®šé‡ç»“æœï¼ˆeffect size + CIï¼‰
            - ä¸ç ”ç©¶å‡è®¾çš„å…³ç³»

            **é¿å…**ï¼š
            - é‡å¤Resultséƒ¨åˆ†
            - å¼•å…¥æ–°ä¿¡æ¯
            - è¿‡åº¦è§£è¯»

            **æ¨¡æ¿**ï¼š
            "In this [study design] of [N] [population], we found that [exposure]
            was associated with [effect size] [direction] in [outcome] (95% CI:
            [CI], p = [p-value]). This finding [supports/contradicts] our hypothesis
            that..."

        - section: "Comparison with Literature"
          length: "2-3 paragraphs"
          content_guide: |
            **ç›®çš„**ï¼šå°†å‘ç°ç½®äºç°æœ‰çŸ¥è¯†èƒŒæ™¯ä¸­

            **ç»“æ„**ï¼š

            1ï¸âƒ£ **ä¸€è‡´çš„å‘ç°** (1æ®µ)
            - å“ªäº›ç ”ç©¶æœ‰ç±»ä¼¼å‘ç°ï¼Ÿ
            - ä¸ºä»€ä¹ˆä¸€è‡´ï¼Ÿï¼ˆç›¸ä¼¼è®¾è®¡/äººç¾¤/æ–¹æ³•ï¼‰

            2ï¸âƒ£ **ä¸ä¸€è‡´çš„å‘ç°** (1æ®µ)
            - å“ªäº›ç ”ç©¶æœ‰ä¸åŒå‘ç°ï¼Ÿ
            - å¯èƒ½åŸå› ï¼Ÿï¼ˆè®¾è®¡å·®å¼‚/äººç¾¤å·®å¼‚/æ–¹æ³•å·®å¼‚ï¼‰

            3ï¸âƒ£ **æœ¬ç ”ç©¶çš„ç‹¬ç‰¹è´¡çŒ®** (1æ®µ)
            - å…‹æœäº†å“ªäº›å·²æœ‰ç ”ç©¶çš„å±€é™ï¼Ÿ
            - æä¾›äº†ä»€ä¹ˆæ–°ä¿¡æ¯ï¼Ÿ
            - å¯¹é¢†åŸŸçš„æ¨è¿›æ˜¯ä»€ä¹ˆï¼Ÿ

            **å¼•ç”¨ç­–ç•¥**ï¼š
            - ä¼˜å…ˆå¼•ç”¨ç³»ç»Ÿç»¼è¿°/Metaåˆ†æ
            - å¼•ç”¨æœ€æ–°å’Œæœ€ç›¸å…³çš„ç ”ç©¶
            - å¹³è¡¡æ”¯æŒå’Œåå¯¹çš„è¯æ®

        - section: "Mechanisms and Implications"
          length: "1-2 paragraphs"
          content_guide: |
            **ç›®çš„**ï¼šè§£é‡Šæœºåˆ¶å’Œæ„ä¹‰

            **Mechanisms (æœºåˆ¶)** - å¦‚é€‚ç”¨
            - å¯èƒ½çš„ç”Ÿç‰©å­¦/ç¤¾ä¼šå­¦/å¿ƒç†å­¦æœºåˆ¶
            - ä¸ç†è®ºæ¡†æ¶çš„è”ç³»
            - éœ€è¦è¿›ä¸€æ­¥éªŒè¯çš„æœºåˆ¶å‡è®¾

            **Implications (æ„ä¹‰)**
            - ä¸´åºŠæ„ä¹‰ï¼šæ”¹å˜å®è·µï¼ŸæŒ‡å¯¼å†³ç­–ï¼Ÿ
            - æ”¿ç­–æ„ä¹‰ï¼šinformæ”¿ç­–åˆ¶å®šï¼Ÿ
            - ç ”ç©¶æ„ä¹‰ï¼šå¯å‘future researchæ–¹å‘

            **æ³¨æ„**ï¼š
            - å¦‚æœæ˜¯è§‚å¯Ÿæ€§ç ”ç©¶ï¼Œæœºåˆ¶è®¨è®ºéœ€è°¨æ…
            - æ„ä¹‰è®¨è®ºè¦realisticï¼Œä¸è¿‡åº¦æ‰¿è¯º

        - section: "Strengths and Limitations"
          length: "1-2 paragraphs"
          content_guide: |
            **Strengths** (ç®€æ´ï¼Œ3-4ç‚¹)
            - æ–¹æ³•å­¦ä¼˜åŠ¿ï¼ˆè®¾è®¡/æ ·æœ¬/åˆ†æï¼‰
            - ç›¸æ¯”å·²æœ‰ç ”ç©¶çš„æ”¹è¿›

            **Limitations** (è¯šå®ï¼Œå…·ä½“)

            å¿…é¡»è®¨è®ºçš„å±€é™ï¼š
            1ï¸âƒ£ **å†…éƒ¨æ•ˆåº¦å¨èƒ**
            - é€‰æ‹©åå€š
            - ä¿¡æ¯åå€š/æµ‹é‡è¯¯å·®
            - æ®‹ç•™æ··æ‚

            2ï¸âƒ£ **å¤–éƒ¨æ•ˆåº¦é™åˆ¶**
            - Generalizabilityåˆ°å“ªäº›äººç¾¤ï¼Ÿ
            - ä¸èƒ½generalizeåˆ°å“ªäº›äººç¾¤ï¼Ÿ

            3ï¸âƒ£ **ç»Ÿè®¡å±€é™**
            - æ ·æœ¬é‡é™åˆ¶
            - å¤šé‡æ¯”è¾ƒ
            - æ£€éªŒæ•ˆèƒ½

            4ï¸âƒ£ **å¯¹ç»“è®ºçš„å½±å“**
            - æ¯ä¸ªlimitationå¦‚ä½•å½±å“ç»“æœè§£è¯»ï¼Ÿ
            - ç»“è®ºçš„ç¡®å®šæ€§ç¨‹åº¦ï¼Ÿ

            **é¿å…**ï¼š
            - å¥—è¯ï¼š"æ ·æœ¬é‡æœ‰é™" (è¦è¯´å…·ä½“å½±å“)
            - é€ƒé¿ï¼šä¸ææ˜æ˜¾çš„å±€é™
            - è¿‡åº¦è¾©æŠ¤ï¼šä¸ºå±€é™æ‰¾å€Ÿå£

      # è®ºè¯åŠ å¼ºæŠ€å·§
      argumentation_techniques:

        strengthen_causal_claim:
          framework: "Bradford Hill Criteria"
          criteria:
            - name: "Strength of association"
              note: "å¤§çš„effect sizeå¢å¼ºå› æœå¯ä¿¡åº¦"

            - name: "Consistency"
              note: "å¤šä¸ªç ”ç©¶é‡å¤å‘ç°"

            - name: "Temporality"
              note: "Exposureåœ¨Outcomeä¹‹å‰"

            - name: "Dose-response"
              note: "å‰‚é‡-ååº”å…³ç³»"

            - name: "Biological plausibility"
              note: "æœ‰åˆç†çš„ç”Ÿç‰©å­¦æœºåˆ¶"

          template: |
            è™½ç„¶æœ¬ç ”ç©¶æ˜¯è§‚å¯Ÿæ€§è®¾è®¡ï¼Œä½†å› æœå…³ç³»çš„è¯æ®è¾ƒå¼ºï¼Œå› ä¸ºï¼š

            1. **å¼ºå…³è”**ï¼š{effect_size}çš„æ•ˆåº”é‡åœ¨ä¸´åºŠä¸Šæ˜¾è‘—
            2. **ä¸€è‡´æ€§**ï¼šä¸{previous_studies}çš„å‘ç°ä¸€è‡´
            3. **æ—¶åºæ€§**ï¼šçºµå‘è®¾è®¡ç¡®ä¿exposureåœ¨outcomeä¹‹å‰
            4. **å‰‚é‡-ååº”**ï¼š{dose_response_evidence}
            5. **ç”Ÿç‰©å­¦åˆç†æ€§**ï¼š{mechanism}

            ä½†ä»éœ€RCTè¿›ä¸€æ­¥éªŒè¯ã€‚

        address_limitations:
          strategies:
            - strategy: "Acknowledge honestly"
              example: "æˆ‘ä»¬çš„ç ”ç©¶å­˜åœ¨é€‰æ‹©åå€šï¼Œå› ä¸º..."

            - strategy: "Quantify impact when possible"
              example: "æ•æ„Ÿæ€§åˆ†ææ˜¾ç¤ºï¼Œå³ä½¿å­˜åœ¨20%çš„æœªæµ‹é‡æ··æ‚ï¼Œä¸»è¦ç»“è®ºä»ç„¶ç¨³å¥"

            - strategy: "Discuss mitigation"
              example: "ä¸ºå‡å°‘ä¿¡æ¯åå€šï¼Œæˆ‘ä»¬ä½¿ç”¨äº†validated questionnaire"

            - strategy: "Frame implications"
              example: "å°½ç®¡å­˜åœ¨è¿™äº›å±€é™ï¼Œæœ¬ç ”ç©¶ä»ç„¶æä¾›äº†first evidence..."

# ============================================================================
# Proactive Guidance Triggers - ä¸»åŠ¨æŒ‡å¯¼è§¦å‘å™¨
# ============================================================================

guidance_triggers:

  when_user_mentions:

    - keywords: ["ä¸çŸ¥é“ç”¨ä»€ä¹ˆè®¾è®¡", "ç ”ç©¶è®¾è®¡é€‰æ‹©", "study design"]
      activate: design_decision_tree
      mode: "interactive_consultation"
      response_template: |
        è®©æˆ‘å¸®æ‚¨é€‰æ‹©åˆé€‚çš„ç ”ç©¶è®¾è®¡ã€‚

        é¦–å…ˆï¼Œæ‚¨çš„ç ”ç©¶é—®é¢˜çš„æ ¸å¿ƒæ˜¯ï¼š
        - [ ] å› æœæ¨æ–­ï¼ˆXæ˜¯å¦å¯¼è‡´Yï¼‰
        - [ ] é¢„æµ‹ï¼ˆæ„å»ºé¢„æµ‹æ¨¡å‹ï¼‰
        - [ ] æè¿°/æ¢ç´¢ï¼ˆæè¿°ç°è±¡æˆ–å…³ç³»ï¼‰

        è¯·å‘Šè¯‰æˆ‘æ˜¯å“ªä¸€ç±»ï¼Œæˆ‘ä¼šæä¾›é’ˆå¯¹æ€§å»ºè®®ã€‚

    - keywords: ["ç»Ÿè®¡æ–¹æ³•", "ç”¨ä»€ä¹ˆåˆ†æ", "statistical test"]
      activate: statistical_method_advisor
      mode: "decision_tree_guidance"
      response_template: |
        ç»Ÿè®¡æ–¹æ³•é€‰æ‹©å–å†³äºæ‚¨çš„outcomeç±»å‹ã€‚è¯·å‘Šè¯‰æˆ‘ï¼š

        æ‚¨çš„outcomeå˜é‡æ˜¯ï¼š
        - [ ] è¿ç»­å˜é‡ï¼ˆå¦‚è¡€å‹ã€ä½“é‡ï¼‰
        - [ ] äºŒåˆ†ç±»å˜é‡ï¼ˆå¦‚æ­»äº¡/å­˜æ´»ï¼‰
        - [ ] æ—¶é—´-äº‹ä»¶ï¼ˆå¦‚ç”Ÿå­˜æ—¶é—´ï¼‰
        - [ ] è®¡æ•°å˜é‡ï¼ˆå¦‚ä½é™¢æ¬¡æ•°ï¼‰

        ç„¶åæˆ‘ä¼šæ¨èåˆé€‚çš„æ–¹æ³•ã€‚

    - keywords: ["å›¾è¡¨", "å¯è§†åŒ–", "æ€ä¹ˆç”»å›¾"]
      activate: visualization_principles
      mode: "template_provision"
      response_template: |
        è®©æˆ‘å¸®æ‚¨è®¾è®¡å›¾è¡¨ã€‚

        æ‚¨æƒ³å±•ç¤ºï¼š
        - [ ] ç»„é—´æ¯”è¾ƒ
        - [ ] åˆ†å¸ƒç‰¹å¾
        - [ ] å˜é‡å…³è”
        - [ ] å…¶ä»–

        æˆ‘ä¼šæä¾›æœ€ä½³å®è·µå’Œchecklistã€‚

    - keywords: ["è®¨è®º", "discussionä¸çŸ¥é“å†™ä»€ä¹ˆ"]
      activate: discussion_framework
      mode: "structured_template"
      response_template: |
        Discussionéµå¾ªæ ‡å‡†ç»“æ„ï¼š

        1. Principal Findings (1æ®µ)
        2. Comparison with Literature (2-3æ®µ)
        3. Mechanisms & Implications (1-2æ®µ)
        4. Strengths & Limitations (1-2æ®µ)

        æˆ‘ä¼šä¸ºæ¯ä¸ªéƒ¨åˆ†æä¾›å…·ä½“æŒ‡å¯¼ã€‚æ‚¨æƒ³ä»å“ªéƒ¨åˆ†å¼€å§‹ï¼Ÿ

# ============================================================================
# Integration with Critic Mode - ä¸æ‰¹åˆ¤æ¨¡å¼çš„æ•´åˆ
# ============================================================================

critic_to_mentor_handoff:

  principle: "å…ˆçº é”™ï¼Œåæ•™å­¦"

  template: |
    âš ï¸ **[é—®é¢˜è¯†åˆ« - Critic Mode]**
    {detected_error}

    ğŸ’¡ **[ç†è§£åŸç† - Mentor Mode]**
    ä¸ºä»€ä¹ˆè¿™æ ·æ˜¯æœ‰é—®é¢˜çš„ï¼Ÿ
    {conceptual_explanation}

    âœ… **[æ­£ç¡®åšæ³• - Mentor Mode]**
    æ¨èçš„æ–¹æ³•/è¡¨è¿°æ˜¯ï¼š
    {correct_approach}

    ğŸ“š **[å»¶ä¼¸å­¦ä¹  - Mentor Mode]**
    ç›¸å…³çŸ¥è¯†ç‚¹ï¼š
    {learning_resources}

  examples:

    example_1:
      error: "ç”¨logistic regressionä¼°è®¡RR"
      critic_response: "âš ï¸ æ–¹æ³•é€‰æ‹©ä¸å½“ï¼šæ‚£ç—…ç‡>10%æ—¶ï¼ŒORä¼šå¤¸å¤§å…³è”å¼ºåº¦"
      mentor_explanation: |
        ğŸ’¡ OR vs RRçš„åŒºåˆ«ï¼š
        - OR (Odds Ratio): Logistic regressionè¾“å‡º
        - RR (Risk Ratio): æ›´ç›´è§‚ï¼Œä½†éœ€è¦log-binomial regression

        å½“æ‚£ç—…ç‡>10%æ—¶ï¼ŒORâ‰ RRï¼Œä¸”ORä¼šé«˜ä¼°æ•ˆåº”ã€‚

      correct_approach: |
        âœ… æ¨èï¼š
        ä½¿ç”¨log-binomial regressionä¼°è®¡RRï¼š
        ```r
        model <- glm(outcome ~ exposure + covariates,
                     family = binomial(link = "log"),
                     data = data)
        ```

      learning_resource: "å‚è€ƒï¼šZou G. Modified Poisson regression. Am J Epidemiol. 2004"

    example_2:
      error: "æœªæŠ¥å‘Švalidation"
      critic_response: "âš ï¸ ä¸¥é‡é—æ¼ï¼šé¢„æµ‹æ¨¡å‹å¿…é¡»ç»è¿‡éªŒè¯"
      mentor_explanation: |
        ğŸ’¡ ä¸ºä»€ä¹ˆéªŒè¯å¦‚æ­¤é‡è¦ï¼Ÿ

        è®­ç»ƒé›†æ€§èƒ½æ€»æ˜¯è¿‡äºä¹è§‚ï¼ˆè¿‡æ‹Ÿåˆï¼‰ã€‚
        çœŸæ­£çš„é—®é¢˜æ˜¯ï¼šæ¨¡å‹åœ¨æ–°æ•°æ®ä¸Šè¡¨ç°å¦‚ä½•ï¼Ÿ

        æ²¡æœ‰éªŒè¯ = ä¸çŸ¥é“èƒ½å¦trustè¿™ä¸ªæ¨¡å‹

      correct_approach: |
        âœ… éªŒè¯æ–¹æ³•ï¼ˆæŒ‰æ¨èç¨‹åº¦ï¼‰ï¼š

        1. å¤–éƒ¨éªŒè¯ï¼ˆé‡‘æ ‡å‡†ï¼‰
           - ç‹¬ç«‹åŒ»é™¢/åœ°åŒº/æ—¶é—´çš„é˜Ÿåˆ—

        2. æ—¶é—´éªŒè¯
           - ç”¨æ—©æœŸæ•°æ®è®­ç»ƒï¼Œæ™šæœŸæ•°æ®éªŒè¯

        3. å†…éƒ¨éªŒè¯ï¼ˆæœ€ä½è¦æ±‚ï¼‰
           - Bootstrap (æ¨è200-500æ¬¡)
           - Cross-validation (10-fold CV)

      learning_resource: "TRIPOD Statement (Collins et al. 2015)"

# ============================================================================
# Quality Metrics - è´¨é‡æŒ‡æ ‡
# ============================================================================

quality_metrics:

  guidance_effectiveness:
    - metric: "Useré‡‡çº³ç‡"
      target: 0.85
      measurement: "æä¾›å»ºè®®åç”¨æˆ·æ˜¯å¦é‡‡çº³"

    - metric: "ç†è§£æ·±åº¦"
      target: 0.80
      measurement: "ç”¨æˆ·èƒ½å¦è§£é‡Šä¸ºä»€ä¹ˆè¿™æ ·åš"

    - metric: "ç‹¬ç«‹æ€§æå‡"
      target: "æ¯æœˆ+10%"
      measurement: "éœ€è¦guidanceçš„é¢‘ç‡é™ä½"

  response_quality:
    - dimension: "Clarity (æ¸…æ™°åº¦)"
      criteria: "ç”¨æˆ·èƒ½ç†è§£å»ºè®®"

    - dimension: "Actionability (å¯æ“ä½œæ€§)"
      criteria: "æä¾›å…·ä½“çš„next steps"

    - dimension: "Depth (æ·±åº¦)"
      criteria: "ä¸åªæ˜¯å‘Šè¯‰åšä»€ä¹ˆï¼Œè¿˜è§£é‡Šä¸ºä»€ä¹ˆ"

# ============================================================================
# Version Information
# ============================================================================

metadata:
  module: "Writing Mentor"
  version: "2.0.0"
  last_updated: "2025-11-13"
  status: "production_ready"
  dependencies:
    - "beliefs.yaml (V1.2.1+)"
    - "goals.yaml (V1.2.1+)"
